
### [MONDO:0019146](http://purl.obolibrary.org/obo/MONDO_0019146)
**Label:** mendelian susceptibility to mycobacterial diseases

**Subclasses:** [MONDO:0017897](http://purl.obolibrary.org/obo/MONDO_0017897) (autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency), [MONDO:0017899](http://purl.obolibrary.org/obo/MONDO_0017899) (autosomal dominant mendelian susceptibility to mycobacterial diseases due to a partial deficiency), [MONDO:0017898](http://purl.obolibrary.org/obo/MONDO_0017898) (autosomal recessive mendelian susceptibility to mycobacterial diseases due to a partial deficiency), [MONDO:0010386](http://purl.obolibrary.org/obo/MONDO_0010386) (X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency), [MONDO:0012682](http://purl.obolibrary.org/obo/MONDO_0012682) (susceptibility to infection due to TYK2 deficiency), [MONDO:0020530](http://purl.obolibrary.org/obo/MONDO_0020530) (mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency), [MONDO:0008856](http://purl.obolibrary.org/obo/MONDO_0008856) (immunodeficiency 27A), [MONDO:0010389](http://purl.obolibrary.org/obo/MONDO_0010389) (X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency), [MONDO:0013955](http://purl.obolibrary.org/obo/MONDO_0013955) (mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency), [MONDO:0014429](http://purl.obolibrary.org/obo/MONDO_0014429) (autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency), [MONDO:0013956](http://purl.obolibrary.org/obo/MONDO_0013956) (mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency), [MONDO:0013957](http://purl.obolibrary.org/obo/MONDO_0013957) (mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency), [MONDO:0017905](http://purl.obolibrary.org/obo/MONDO_0017905) (X-linked mendelian susceptibility to mycobacterial diseases), [MONDO:0017902](http://purl.obolibrary.org/obo/MONDO_0017902) (autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency), [MONDO:0014710](http://purl.obolibrary.org/obo/MONDO_0014710) (autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency), [MONDO:0014502](http://purl.obolibrary.org/obo/MONDO_0014502) (mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency), [MONDO:0017903](http://purl.obolibrary.org/obo/MONDO_0017903) (autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency), [MONDO:0017900](http://purl.obolibrary.org/obo/MONDO_0017900) (mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency), [MONDO:0013954](http://purl.obolibrary.org/obo/MONDO_0013954) (mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency), [MONDO:0017901](http://purl.obolibrary.org/obo/MONDO_0017901) (autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency), 

**Mapped go classes:** [GO:0042019](http://purl.obolibrary.org/obo/GO_0042019) (interleukin-23 binding), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0045649](http://purl.obolibrary.org/obo/GO_0045649) (regulation of macrophage differentiation), [GO:0007252](http://purl.obolibrary.org/obo/GO_0007252) (I-kappaB phosphorylation), [GO:0007250](http://purl.obolibrary.org/obo/GO_0007250) (activation of NF-kappaB-inducing kinase activity), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0042020](http://purl.obolibrary.org/obo/GO_0042020) (interleukin-23 receptor activity), [GO:0032729](http://purl.obolibrary.org/obo/GO_0032729) (positive regulation of interferon-gamma production), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0016239](http://purl.obolibrary.org/obo/GO_0016239) (positive regulation of macroautophagy), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0016517](http://purl.obolibrary.org/obo/GO_0016517) (interleukin-12 receptor activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0045658](http://purl.obolibrary.org/obo/GO_0045658) (regulation of neutrophil differentiation), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0051650](http://purl.obolibrary.org/obo/GO_0051650) (establishment of vesicle localization), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0072615](http://purl.obolibrary.org/obo/GO_0072615) (interleukin-17 secretion), [GO:0060261](http://purl.obolibrary.org/obo/GO_0060261) (positive regulation of transcription initiation from RNA polymerase II promoter), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0061515](http://purl.obolibrary.org/obo/GO_0061515) (myeloid cell development), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0048537](http://purl.obolibrary.org/obo/GO_0048537) (mucosal-associated lymphoid tissue development), [GO:0048535](http://purl.obolibrary.org/obo/GO_0048535) (lymph node development), [GO:0046632](http://purl.obolibrary.org/obo/GO_0046632) (alpha-beta T cell differentiation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0042832](http://purl.obolibrary.org/obo/GO_0042832) (defense response to protozoan), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0048541](http://purl.obolibrary.org/obo/GO_0048541) (Peyer's patch development), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0033077](http://purl.obolibrary.org/obo/GO_0033077) (T cell differentiation in thymus), [GO:0038083](http://purl.obolibrary.org/obo/GO_0038083) (peptidyl-tyrosine autophosphorylation), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0001782](http://purl.obolibrary.org/obo/GO_0001782) (B cell homeostasis), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0019218](http://purl.obolibrary.org/obo/GO_0019218) (regulation of steroid metabolic process), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0008385](http://purl.obolibrary.org/obo/GO_0008385) (IkappaB kinase complex), [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding), [GO:1902236](http://purl.obolibrary.org/obo/GO_1902236) (negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:1990450](http://purl.obolibrary.org/obo/GO_1990450) (linear polyubiquitin binding), [GO:0042975](http://purl.obolibrary.org/obo/GO_0042975) (peroxisome proliferator activated receptor binding), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0098531](http://purl.obolibrary.org/obo/GO_0098531) (transcription factor activity, direct ligand regulated sequence-specific DNA binding), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0032922](http://purl.obolibrary.org/obo/GO_0032922) (circadian regulation of gene expression), [GO:0070244](http://purl.obolibrary.org/obo/GO_0070244) (negative regulation of thymocyte apoptotic process), [GO:0016175](http://purl.obolibrary.org/obo/GO_0016175) (superoxide-generating NADPH oxidase activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0043276](http://purl.obolibrary.org/obo/GO_0043276) (anoikis), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0002573](http://purl.obolibrary.org/obo/GO_0002573) (myeloid leukocyte differentiation), [GO:0031702](http://purl.obolibrary.org/obo/GO_0031702) (type 1 angiotensin receptor binding), [GO:0010906](http://purl.obolibrary.org/obo/GO_0010906) (regulation of glucose metabolic process), [GO:0000151](http://purl.obolibrary.org/obo/GO_0000151) (ubiquitin ligase complex), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0006805](http://purl.obolibrary.org/obo/GO_0006805) (xenobiotic metabolic process), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0072539](http://purl.obolibrary.org/obo/GO_0072539) (T-helper 17 cell differentiation), [GO:0019955](http://purl.obolibrary.org/obo/GO_0019955) (cytokine binding), [GO:0036315](http://purl.obolibrary.org/obo/GO_0036315) (cellular response to sterol), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0005131](http://purl.obolibrary.org/obo/GO_0005131) (growth hormone receptor binding), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0045586](http://purl.obolibrary.org/obo/GO_0045586) (regulation of gamma-delta T cell differentiation), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042753](http://purl.obolibrary.org/obo/GO_0042753) (positive regulation of circadian rhythm), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0072686](http://purl.obolibrary.org/obo/GO_0072686) (mitotic spindle), [GO:0004715](http://purl.obolibrary.org/obo/GO_0004715) (non-membrane spanning protein tyrosine kinase activity), [GO:0032620](http://purl.obolibrary.org/obo/GO_0032620) (interleukin-17 production), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0060850](http://purl.obolibrary.org/obo/GO_0060850) (regulation of transcription involved in cell fate commitment), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0000922](http://purl.obolibrary.org/obo/GO_0000922) (spindle pole), [GO:0005143](http://purl.obolibrary.org/obo/GO_0005143) (interleukin-12 receptor binding), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0045598](http://purl.obolibrary.org/obo/GO_0045598) (regulation of fat cell differentiation), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0032735](http://purl.obolibrary.org/obo/GO_0032735) (positive regulation of interleukin-12 production), [GO:0042093](http://purl.obolibrary.org/obo/GO_0042093) (T-helper cell differentiation), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0048511](http://purl.obolibrary.org/obo/GO_0048511) (rhythmic process), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0071346](http://purl.obolibrary.org/obo/GO_0071346) (cellular response to interferon-gamma), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0014005](http://purl.obolibrary.org/obo/GO_0014005) (microglia development), 

**Class expressions from DL-Learner:**

- Thing 54.14%
- [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity) 52.38%
- [GO:1990450](http://purl.obolibrary.org/obo/GO_1990450) (linear polyubiquitin binding) 51.19%
- [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding) 51.19%
- [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity) 51.19%
- [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding) 51.19%
- [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity) 51.19%
- [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding) 51.19%
- [GO:0042020](http://purl.obolibrary.org/obo/GO_0042020) (interleukin-23 receptor activity) 51.19%
- [GO:0042019](http://purl.obolibrary.org/obo/GO_0042019) (interleukin-23 binding) 51.19%
- [GO:0016517](http://purl.obolibrary.org/obo/GO_0016517) (interleukin-12 receptor activity) 51.19%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 51.19%
- [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity) 51.19%
- [GO:0032182](http://purl.obolibrary.org/obo/GO_0032182) (ubiquitin-like protein binding) 36.55%
- [GO:0031593](http://purl.obolibrary.org/obo/GO_0031593) (polyubiquitin modification-dependent protein binding) 36.55%


